These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14742521)

  • 41. Adsorption of a statherin peptide fragment on the surface of nanocrystallites of hydroxyapatite.
    Chen PH; Tseng YH; Mou Y; Tsai YL; Guo SM; Huang SJ; Yu SS; Chan JC
    J Am Chem Soc; 2008 Mar; 130(9):2862-8. PubMed ID: 18266360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delineation of a segment of adsorbed salivary acidic proline-rich proteins which promotes adhesion of Streptococcus gordonii to apatitic surfaces.
    Gibbons RJ; Hay DI; Schlesinger DH
    Infect Immun; 1991 Sep; 59(9):2948-54. PubMed ID: 1879920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A (13)C{(31)P} REDOR NMR investigation of the role of glutamic acid residues in statherin- hydroxyapatite recognition.
    Ndao M; Ash JT; Breen NF; Goobes G; Stayton PS; Drobny GP
    Langmuir; 2009 Oct; 25(20):12136-43. PubMed ID: 19678690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Solid-phase synthesis and characterization of human salivary statherin: a tyrosine-rich phosphoprotein inhibitor of calcium phosphate precipitation.
    Gururaja TL; Levine MJ
    Pept Res; 1996; 9(6):283-9. PubMed ID: 9048421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HPLC-MS characterization of cyclo-statherin Q-37, a specific cyclization product of human salivary statherin generated by transglutaminase 2.
    Cabras T; Inzitari R; Fanali C; Scarano E; Patamia M; Sanna MT; Pisano E; Giardina B; Castagnola M; Messana I
    J Sep Sci; 2006 Nov; 29(17):2600-8. PubMed ID: 17313100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection in human saliva of different statherin and P-B fragments and derivatives.
    Inzitari R; Cabras T; Rossetti DV; Fanali C; Vitali A; Pellegrini M; Paludetti G; Manni A; Giardina B; Messana I; Castagnola M
    Proteomics; 2006 Dec; 6(23):6370-9. PubMed ID: 17080484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of human salivary cystatins and statherin on hydroxyapatite crystallization.
    Johnsson M; Richardson CF; Bergey EJ; Levine MJ; Nancollas GH
    Arch Oral Biol; 1991; 36(9):631-6. PubMed ID: 1741693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complete covalent structure of statherin, a tyrosine-rich acidic peptide which inhibits calcium phosphate precipitation from human parotid saliva.
    Schlesinger DH; Hay DI
    J Biol Chem; 1977 Mar; 252(5):1689-95. PubMed ID: 838735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complete primary structure of statherin, a potent inhibitor of calcium phosphate precipitation, from the saliva of the monkey, Macaca arctoides.
    Schlesinger DH; Hay DI; Levine MJ
    Int J Pept Protein Res; 1989 Nov; 34(5):374-80. PubMed ID: 2613439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A solid-state NMR study of the dynamics and interactions of phenylalanine rings in a statherin fragment bound to hydroxyapatite crystals.
    Gibson JM; Popham JM; Raghunathan V; Stayton PS; Drobny GP
    J Am Chem Soc; 2006 Apr; 128(16):5364-70. PubMed ID: 16620107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural features of salivary function.
    Lamkin MS; Oppenheim FG
    Crit Rev Oral Biol Med; 1993; 4(3-4):251-9. PubMed ID: 8373982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular mapping of statherin- and histatin-binding domains in human salivary mucin MG1 (MUC5B) by the yeast two-hybrid system.
    Iontcheva I; Oppenheim FG; Offner GD; Troxler RF
    J Dent Res; 2000 Feb; 79(2):732-9. PubMed ID: 10728974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thermodynamics of statherin adsorption onto hydroxyapatite.
    Goobes R; Goobes G; Campbell CT; Stayton PS
    Biochemistry; 2006 May; 45(17):5576-86. PubMed ID: 16634639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural characterization of a new statherin from pig parotid granules.
    Manconi B; Fanali C; Cabras T; Inzitari R; Patamia M; Scarano E; Fiorita A; Vitali A; Castagnola M; Messana I; Sanna MT
    J Pept Sci; 2010 Jun; 16(6):269-75. PubMed ID: 20474038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Active sites of salivary proline-rich protein for binding to Porphyromonas gingivalis fimbriae.
    Kataoka K; Amano A; Kuboniwa M; Horie H; Nagata H; Shizukuishi S
    Infect Immun; 1997 Aug; 65(8):3159-64. PubMed ID: 9234769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Solution- and adsorbed-state structural ensembles predicted for the statherin-hydroxyapatite system.
    Masica DL; Gray JJ
    Biophys J; 2009 Apr; 96(8):3082-91. PubMed ID: 19383454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interactions between Streptococcus oralis, Actinomyces oris, and Candida albicans in the development of multispecies oral microbial biofilms on salivary pellicle.
    Cavalcanti IM; Del Bel Cury AA; Jenkinson HF; Nobbs AH
    Mol Oral Microbiol; 2017 Feb; 32(1):60-73. PubMed ID: 26834007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pellicle receptors for Actinomyces viscosus type 1 fimbriae in vitro.
    Clark WB; Beem JE; Nesbitt WE; Cisar JO; Tseng CC; Levine MJ
    Infect Immun; 1989 Oct; 57(10):3003-8. PubMed ID: 2570751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemical synthesis of phosphoseryl-phosphoserine, a partial analogue of human salivary statherin, a protein inhibitor of calcium phosphate precipitation in human saliva.
    Schlesinger DH; Buku A; Wyssbrod HR; Hay DI
    Int J Pept Protein Res; 1987 Aug; 30(2):257-62. PubMed ID: 3679674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coaggregation of Candida albicans with oral Actinomyces species.
    Grimaudo NJ; Nesbitt WE; Clark WB
    Oral Microbiol Immunol; 1996 Feb; 11(1):59-61. PubMed ID: 8604256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.